Gabapentin for treatment of restless legs syndrome among hemodialysis patients; a pilot study

Gabapentin for treatment of restless legs syndrome among hemodialysis patients; a pilot study

Introduction: Unfortunately the restless leg syndrome (RLS) is a neglected issue among hemodialysis (HD) centers. Objectives: The aim of our study was to find the efficacy of gabapentin at a low dose of 100 mg three times a week among HD patients with RLS. Patients and Methods: Around 21 patients w...

Full description

Bibliographic Details
Main Authors: Seyed Majid Mousavi Movahed, Gholamreza Alizadeh Attar, Fatemeh Hayati, Shahla Ahmadi Halili, Leila Sabetnia, Seyed Seifollah Beladi Mousavi
Format: Article
Language:English
Published: Society of Diabetic Nephropathy Prevention 2018-05-01
Series:Journal of Nephropharmacology
Subjects:
End-stage renal disease
Gabapentin
Restless legs syndrome
Hemodialysis
Online Access:http://jnephropharmacology.com/PDF/npj-7-104.pdf

Similar Items

Similar Items